Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carmen Chang

Affiliations

  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-17
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2019-06-25
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2019-05-13
  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2019-05-09
  • Large Shareholder at Marker Therapeutics Inc. (MRKR), 2018-10-18
  • Large Shareholder at Arsanis Inc. (ASNS), 2018-07-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GNCA $3.50 2,857,142 Large Shareholder 7,225,676 2019-06-24 Filing
TRVI $10.00 1,500,000 Large Shareholder 4,438,562 2019-05-09 Filing
TRVI $10.00 1,000,000 Large Shareholder 2,938,562 2019-05-09 Filing
RGLS $1.08 1,136,704 Large Shareholder 2,052,454 2019-05-07 Filing
GNCA $0.47 9,948,269 Large Shareholder 34,948,269 2019-02-14 Filing